Logo image
以桿狀病毒表現系統生產重組蛋白質疫苗之產程開發與最適化
Thesis

以桿狀病毒表現系統生產重組蛋白質疫苗之產程開發與最適化

高宜均
Masters, 國立清華大學, 化學工程學系
2012

Abstract

桿狀病毒 蛋白質疫苗
The baculovirus/insect cell expression system is widely used for the production of recombinant proteins. To exploit the potential of baculovirus system for vaccine production, this study aimed to develop efficient strategies for the production of porcine circovirus type II (PCV2) capsid protein and enterovirus 71 (EV71) virus-like particles (VLP) by genetic and bioreactor engineering approaches. In the first part of this study, we employed baculovirus as a tool for mass production of EV71 VLP using BelloCell® bioreactor, which is a 500 ml, disposable packed-bed bioreactor. We optimized the production conditions in the process, including culture medium, time of infection (TOI) and bioreactor parameters to improve the volumetric yield of EV71 VLP. After determining the process parameters in BelloCell® system, we further scaled the production process up using a 10 liter TideCell® bioreactor for pilot production of EV71 VLP. With the process optimization, the VLP yield was tremendously enhanced to 250-300 mg/L. In the second part of this study, we employed baculovirus system for the production of the major antigen (Cap protein) of PCV2. We designed multiple recombinant baculoviruses in order to change the location of Cap. After modification, the Cap protein resided in the cytoplasm instead of being retained in the nucleus, which led to the enhanced yield to 170 mg/L. We also successfully developed a simple method to extract intracellular product, making it simpler for downstream bioseparation. These works collectively contributed to the optimized production of the PCV2 and EV71 vaccines.

Metrics

1 Record Views

Details

Logo image